Singapore markets open in 4 hours 50 minutes

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.04+0.30 (+5.15%)
At close: 03:59PM EDT
6.18 +0.14 (+2.35%)
After hours: 04:09PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.60M
Enterprise value 54.12M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.35
Price/book (mrq)40.35
Enterprise value/revenue 1.97
Enterprise value/EBITDA -1.34

Trading information

Stock price history

Beta (5Y monthly) 1.93
52-week change 3-88.92%
S&P500 52-week change 325.59%
52-week high 352.56
52-week low 34.90
50-day moving average 37.71
200-day moving average 311.66

Share statistics

Avg vol (3-month) 345.13k
Avg vol (10-day) 315.16k
Shares outstanding 51.67M
Implied shares outstanding 630.1M
Float 8511.57k
% held by insiders 137.68%
% held by institutions 137.03%
Shares short (15 Apr 2024) 45.84k
Short ratio (15 Apr 2024) 41.54
Short % of float (15 Apr 2024) 41.91%
Short % of shares outstanding (15 Apr 2024) 40.35%
Shares short (prior month 15 Mar 2024) 412.57k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:18
Last split date 309 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -173.49%
Operating margin (ttm)-87.32%

Management effectiveness

Return on assets (ttm)-28.95%
Return on equity (ttm)-125.42%

Income statement

Revenue (ttm)27.51M
Revenue per share (ttm)16.59
Quarterly revenue growth (yoy)-26.30%
Gross profit (ttm)N/A
EBITDA -32.83M
Net income avi to common (ttm)-49.02M
Diluted EPS (ttm)-29.52
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.16M
Total cash per share (mrq)11.45
Total debt (mrq)34.38M
Total debt/equity (mrq)116.39%
Current ratio (mrq)3.71
Book value per share (mrq)0.14

Cash flow statement

Operating cash flow (ttm)-34.67M
Levered free cash flow (ttm)-23.24M